CN111990641A - Alcohol-dispelling liver-protecting tablet and construction method thereof - Google Patents
Alcohol-dispelling liver-protecting tablet and construction method thereof Download PDFInfo
- Publication number
- CN111990641A CN111990641A CN202010372855.2A CN202010372855A CN111990641A CN 111990641 A CN111990641 A CN 111990641A CN 202010372855 A CN202010372855 A CN 202010372855A CN 111990641 A CN111990641 A CN 111990641A
- Authority
- CN
- China
- Prior art keywords
- powder
- alcohol
- liver
- mixing
- construction method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010276 construction Methods 0.000 title claims description 18
- 239000000843 powder Substances 0.000 claims abstract description 207
- 238000002156 mixing Methods 0.000 claims abstract description 81
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 42
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 39
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 39
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 39
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 39
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 39
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 39
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 39
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 39
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 39
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 39
- 238000000576 coating method Methods 0.000 claims abstract description 33
- 239000011248 coating agent Substances 0.000 claims abstract description 32
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 28
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 28
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- 230000002075 anti-alcohol Effects 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 19
- 230000000694 effects Effects 0.000 claims abstract description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 16
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 16
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 14
- 241000237502 Ostreidae Species 0.000 claims abstract description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940116298 l- malic acid Drugs 0.000 claims abstract description 14
- 239000008101 lactose Substances 0.000 claims abstract description 14
- 235000011090 malic acid Nutrition 0.000 claims abstract description 14
- 235000020636 oyster Nutrition 0.000 claims abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 14
- 229960003080 taurine Drugs 0.000 claims abstract description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 8
- 239000004471 Glycine Substances 0.000 claims abstract description 8
- 239000004395 L-leucine Substances 0.000 claims abstract description 8
- 235000019454 L-leucine Nutrition 0.000 claims abstract description 8
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 8
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 8
- 240000008042 Zea mays Species 0.000 claims abstract description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 8
- 201000007930 alcohol dependence Diseases 0.000 claims abstract description 8
- 235000005822 corn Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 8
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 8
- 229960003136 leucine Drugs 0.000 claims abstract description 8
- 239000000047 product Substances 0.000 claims description 42
- 206010019133 Hangover Diseases 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 40
- 239000002346 layers by function Substances 0.000 claims description 39
- 241001092040 Crataegus Species 0.000 claims description 38
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 38
- 239000010410 layer Substances 0.000 claims description 37
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 244000046146 Pueraria lobata Species 0.000 claims description 34
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 34
- 239000008187 granular material Substances 0.000 claims description 33
- 210000004185 liver Anatomy 0.000 claims description 31
- 239000008367 deionised water Substances 0.000 claims description 30
- 229910021641 deionized water Inorganic materials 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 28
- 240000006079 Schisandra chinensis Species 0.000 claims description 26
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 25
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 25
- 241000304195 Salvia miltiorrhiza Species 0.000 claims description 25
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 25
- 239000012065 filter cake Substances 0.000 claims description 24
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 22
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 19
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 19
- 235000012754 curcumin Nutrition 0.000 claims description 19
- 239000004148 curcumin Substances 0.000 claims description 19
- 229940109262 curcumin Drugs 0.000 claims description 19
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims description 19
- 235000012907 honey Nutrition 0.000 claims description 19
- 235000012661 lycopene Nutrition 0.000 claims description 19
- 229960004999 lycopene Drugs 0.000 claims description 19
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 19
- 239000001751 lycopene Substances 0.000 claims description 19
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 18
- 239000011265 semifinished product Substances 0.000 claims description 18
- 239000011343 solid material Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 15
- 239000011247 coating layer Substances 0.000 claims description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 108010011485 Aspartame Proteins 0.000 claims description 13
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 13
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 13
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 13
- 229940024606 amino acid Drugs 0.000 claims description 13
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 13
- 239000000605 aspartame Substances 0.000 claims description 13
- 229960003438 aspartame Drugs 0.000 claims description 13
- 235000010357 aspartame Nutrition 0.000 claims description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 13
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 13
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 13
- 229960000367 inositol Drugs 0.000 claims description 13
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 13
- 235000011477 liquorice Nutrition 0.000 claims description 13
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 13
- 239000011593 sulfur Substances 0.000 claims description 13
- 229910052717 sulfur Inorganic materials 0.000 claims description 13
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 12
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 12
- 229960004998 acesulfame potassium Drugs 0.000 claims description 12
- 239000000619 acesulfame-K Substances 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000845 maltitol Substances 0.000 claims description 12
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 12
- 235000010449 maltitol Nutrition 0.000 claims description 12
- 229940035436 maltitol Drugs 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 235000013336 milk Nutrition 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 238000000465 moulding Methods 0.000 claims description 12
- 210000000582 semen Anatomy 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 7
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 235000015165 citric acid Nutrition 0.000 claims description 7
- 229960001031 glucose Drugs 0.000 claims description 7
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 7
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 235000001508 sulfur Nutrition 0.000 claims description 6
- 241000235342 Saccharomycetes Species 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 2
- 244000111489 Gardenia augusta Species 0.000 claims 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 241000157835 Gardenia Species 0.000 description 21
- 210000002249 digestive system Anatomy 0.000 description 19
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 12
- 229940010454 licorice Drugs 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 230000002411 adverse Effects 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000035790 physiological processes and functions Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000029142 excretion Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- SKIVFJLNDNKQPD-UHFFFAOYSA-N sulfacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 SKIVFJLNDNKQPD-UHFFFAOYSA-N 0.000 description 1
- 229960002673 sulfacetamide Drugs 0.000 description 1
- -1 sulfur amino acid Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to an anti-alcohol liver-protecting tablet which comprises the following components in percentage by mass: 10-22% of hawthorn, 3-7% of radix puerariae, 8.5-17% of corn oligopeptide powder, 6.3-12.3% of oyster peptide, 2.5-5.8% of xylo-oligosaccharide, 1.3-2.7% of vitamin C, 1.1-3.5% of L-leucine, 0.3-1.4% of L-glutamic acid, 0.05-0.15% of L-cysteine, 0.11-1.4% of glycine, 0.8-3.5% of citric acid, 1.5-3.5% of L-malic acid, 0.3-1.8% of taurine and the balance of lactose. The preparation method comprises the five steps of preparing extract powder, mixing materials, preparing solution, granulating, coating and the like. The invention has wide raw material sources, low cost and small toxic and side effects, can fully exert the efficacy of each component, and greatly improve the capabilities of relieving alcoholism, sobering up and nourishing human bodies.
Description
Technical Field
The invention relates to an anti-alcohol liver-protecting tablet and a construction method thereof, belonging to the technical field of health-care food.
Background
The anti-alcohol tablet, the anti-alcohol agent and other products on the market are used in huge quantities, but the anti-alcohol principle of the anti-alcohol tablet, the anti-alcohol agent and other products is usually two types of alcohol absorption inhibiting type and dry metabolism promoting type, wherein after the anti-alcohol product for inhibiting alcohol absorption is taken, the function of a human digestive system is usually inhibited, so that the alcohol absorption capacity of the human body is reduced, the functional disorder of the human digestive system can be caused, great discomfort can be caused to the human body, and meanwhile, the effective auxiliary treatment capacity is lacked for alcohol entering human blood and entering liver along with the blood, so that the adverse effect time of the alcohol on the human body is longer while the alcohol decomposition burden of the human liver is increased; the traditional Chinese medicine components such as the kudzu root and the hawthorn lamp act on the liver, the stomach, the kidney and other systems of the human body to improve the decomposition capacity and the whole metabolism level of the human body to alcohol, and accelerate the reduction of the alcohol concentration in the blood of the human body and the reduction of the alcohol content in the human body.
Meanwhile, various anti-alcohol products used at present often directly participate in anti-alcohol and sober-up physiological activities after being eaten, but due to serious differences of physiological levels of digestive system and liver functions of users, especially when the anti-alcohol products are used by people with poor digestive system capability, low liver function and the like, the performance of the effectiveness of the current anti-alcohol products is seriously influenced, and meanwhile, the anti-alcohol products increase the digestive burden of human bodies and the liver detoxification burden due to the fact that the anti-alcohol products are not fully and slowly exerted, and further harm is caused to the human bodies.
Therefore, although various existing anti-inebriation products can achieve the aim of anti-inebriation to a certain extent, the existing anti-inebriation products have poor stability of anti-inebriation effect to different extents, and can cause adverse effects on organs of human bodies such as intestines, stomachs and livers to different extents.
Therefore, in view of the current situation, a brand-new anti-hangover product and a preparation process thereof are urgently needed to meet the needs of practical use.
Disclosure of Invention
The invention aims to overcome the defects and provides an anti-alcohol liver-protecting tablet and a preparation method thereof.
In order to realize the purpose, the invention is realized by the following technical scheme:
an anti-alcohol liver-protecting tablet comprises the following substances in percentage by mass: 10-22% of hawthorn, 3-7% of radix puerariae, 8.5-17% of corn oligopeptide powder, 6.3-12.3% of oyster peptide, 2.5-5.8% of xylo-oligosaccharide, 1.3-2.7% of vitamin C, 1.1-3.5% of L-leucine, 0.3-1.4% of L-glutamic acid, 0.05-0.15% of L-cysteine, 0.11-1.4% of glycine, 0.8-3.5% of citric acid, 1.5-3.5% of L-malic acid, 0.3-1.8% of taurine, 0.01-0.21% of aspartame (containing phenylalanine), 0.3-0.35% of acesulfame potassium, 1.3-2.7% of magnesium stearate, 0.1-0.4% of lycopene, 0.3-1.1% of curcumin and the balance of lactose.
A preparation method of an anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 90-110 ℃, wherein the decocting time is 1-2 hours each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the filtered decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 60-80 ℃ to obtain thick paste with the relative density of 1.35-1.38 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain extract powder of 80-500 meshes;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 20-40 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 10-30 minutes after mixing for 1-3 minutes, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding the lycopene into 1-4 kg of deionized water and uniformly mixing for later use, and simultaneously adding the curcumin into 1-4 kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, a lycopene water solution is added into a mixer and mixed with solid materials in the mixer, the mixture is stirred and mixed for 5-15 minutes through the mixer, the mixture is filtered through a 12-20-mesh screen, the filtered mixed materials are added into the mixer again, a curcumin water solution is added into the mixer and mixed and stirred for 2-10 minutes, finally the mixture is transferred into a granulator and granulated through a 12-20-mesh screen, the prepared semi-finished granules are dried for 1-2 hours at 50-60 ℃ in a hot air circulation oven, and finally, the granules are granulated through a 14-20-mesh screen to obtain finished product particles for dispelling effects of alcohol;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 1-5 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
Further, the residual hawthorn and kudzu vine root residues and the filtered filter residues after the processing treatment in the step S1 are gathered, then yeast accounting for 1% -10% of the total amount of the residues and the filter residues is added into the residues and the filter residues and uniformly mixed, then the mixture is pressed into a filter cake with a block structure, the thickness of the filter cake is 3-10 cm, the length and the width of the filter cake are not more than 30 cm, and the water content of the filter cake is not more than 4%.
Furthermore, the total amount of the deionized water in the step S1 is 2.5-5 times of the total amount of the hawthorn and the kudzuvine root.
Further, in the step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 10% to 30% of the thickness of the auxiliary layer.
Further, the auxiliary layer is composed of the following substances in percentage by mass: 10-15% of schisandra chinensis powder, 3-7% of salvia miltiorrhiza powder, 3.5-7% of liquorice powder, 2.3-5.3% of gardenia powder, 11-21% of yam powder, 5.3-11.7% of cassia seed powder and the balance of refined honey.
Furthermore, the schisandra chinensis powder, the salvia miltiorrhiza powder, the liquorice powder, the gardenia powder, the yam powder and the cassia seed powder are all 20-100 meshes, and the schisandra chinensis powder, the salvia miltiorrhiza powder, the liquorice powder, the gardenia powder, the yam powder and the cassia seed powder are all freeze-dried powders.
Further, the functional layer is composed of the following substances in percentage by mass: 10-15% of L-arabinose, 5-11% of maltitol, 3.5-7.1% of carboxymethyl cellulose, 2.3-5.3% of sulfur-containing amino acid, 2.5-4.1% of inositol, 8.6-14.5% of glucose, 1-2.5% of acetic acid bacteria freeze-dried powder and the balance of milk powder.
A construction method of an anti-alcohol liver-protecting tablet comprises the following steps of:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria freeze-dried bacteria powder and milk powder at the constant temperature of 20-40 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and carrying out air drying operation by cold wind at-5 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
The invention has wide raw material sources, low cost and small toxic and side effects, can fully exert the efficacies of each component, greatly improve the capabilities of relieving alcoholism, sobering up and nourishing human bodies, and simultaneously can effectively reduce the absorption efficiency and the absorption amount of the human bodies to alcohol, effectively improve the metabolism level of the human bodies and accelerate the decomposition capability of the human bodies to the alcohol and the excretion capability of the alcohol from the human bodies on the one hand, thereby achieving the purposes of quickly relieving alcoholism and sobering up and reducing the adverse effects of the alcohol on the digestive system and the nervous system of the human bodies; on the other hand, the alcohol-containing liver-protecting health-care wine can effectively reduce the damage of alcohol to the liver, prevent fat from accumulating at the liver part, effectively improve the regeneration capacity of stem cells, recover and improve the comprehensive physiological function of the liver, promote bile secretion, further improve the digestive capacity of a human body, eliminate the burden and adverse effect of alcohol on the digestive system of the human body, and quickly recover the physiological function of the human body, thereby effectively realizing the liver nourishing and protecting capacity while improving the capacity of dispelling the effects of alcohol.
Drawings
FIG. 1 is a schematic flow diagram of the process of the present invention;
FIG. 2 is a flow chart of the coating process.
Detailed Description
Example 1
As shown in fig. 1, an anti-hangover and liver-protecting tablet comprises the following components in percentage by mass: 10% of hawthorn, 3% of kudzuvine root, 8.5% of corn oligopeptide powder, 6.3% of oyster peptide, 2.5% of xylo-oligosaccharide, 1.3% of vitamin C, 1.1% of L-leucine, 0.3% of L-glutamic acid, 0.05% of L-cysteine, 0.11% of glycine, 0.8% of citric acid, 1.5% of L-malic acid, 0.3% of taurine, 0.01% of aspartame (containing phenylalanine), 0.3% of potassium sulfacetamide, 1.3% of magnesium stearate, 0.1% of lycopene, 0.3% of curcumin and the balance of lactose.
A preparation method of an anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 90 ℃, wherein the decocting time is 1 hour each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to the normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the filtered secondary decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 60 ℃ to obtain thick paste with the relative density of 1.35 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain 80-mesh extract powder;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 20 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 10 minutes after mixing for 1 minute, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding lycopene into 1kg of deionized water and uniformly mixing for later use, and simultaneously adding curcumin into 1kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, a lycopene aqueous solution is added into a mixer and mixed with solid materials in the mixer, then the mixture is stirred and mixed for 5 minutes through the mixer, then the mixture is filtered through a 12-mesh screen, the filtered mixed materials are added into the mixer again, then a curcumin aqueous solution is added into the mixer and mixed and stirred for 2 minutes, finally the mixture is transferred into a granulator and granulated through the 12-mesh screen, then the prepared semi-finished granules are dried for 1 hour at 50 ℃ in a hot air circulation oven, and finally granules are granulated through a 14-mesh screen to obtain finished product hangover alleviating granules;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 1 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
And C, concentrating the residual hawthorn and kudzu vine root residues and the filtered filter residues after the processing treatment in the step S1, adding saccharomycetes accounting for 1% of the total amount of the residues and the filter residues into the residues and the filter residues, uniformly mixing, pressing into a filter cake with a block structure, wherein the thickness of the filter cake is 3 cm, the length and the width of the filter cake are not more than 10 cm, and the water content of the filter cake is not more than 4%.
Meanwhile, the total amount of the deionized water in the step S1 is 2.5 times of the total amount of the hawthorn and the kudzuvine root.
It is emphasized that, in the step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 10% of the thickness of the auxiliary layer.
Further, the auxiliary layer is composed of the following substances in percentage by mass: the Chinese magnoliavine fruit honey powder comprises 10% of Chinese magnoliavine fruit powder, 3% of salvia miltiorrhiza powder, 3.5% of licorice powder, 2.3% of gardenia powder, 11% of yam powder, 5.3% of cassia seed powder and the balance of refined honey, wherein the Chinese magnoliavine fruit powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the cassia seed powder are all 20 meshes, and the Chinese magnoliavine fruit powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the cassia seed powder are all.
Meanwhile, the functional layer consists of the following substances in percentage by mass: 10% of L-arabinose, 5% of maltitol, 3.5% of carboxymethyl cellulose, 2.3% of sulfur-containing amino acid, 2.5% of inositol, 8.6% of glucose, 1% of acetic acid bacteria freeze-dried powder and the balance of milk powder.
As shown in fig. 2, a method for constructing an anti-hangover and liver-protecting tablet, comprises the following steps:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria lyophilized bacteria powder and milk powder at the constant temperature of 20 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and performing air drying operation by using cold air at the temperature of-5 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
Example 2
As shown in fig. 1, an anti-hangover and liver-protecting tablet comprises the following components in percentage by mass: 22% of hawthorn, 7% of kudzuvine root, 17% of corn oligopeptide powder, 12.3% of oyster peptide, 5.8% of xylo-oligosaccharide, 2.7% of vitamin C, 3.5% of L-leucine, 1.4% of L-glutamic acid, 0.15% of L-cysteine, 1.4% of glycine, 3.5% of citric acid, 3.5% of L-malic acid, 1.8% of taurine, 0.21% of aspartame (containing phenylalanine), 0.35% of acesulfame potassium, 2.7% of magnesium stearate, 0.4% of lycopene, 1.1% of curcumin and the balance of lactose.
A preparation method of an anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 110 ℃, wherein the decocting time is 2 hours each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to the normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the filtered secondary decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 80 ℃ to obtain thick paste with the relative density of 1.38 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain extract powder of 500 meshes;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 40 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 30 minutes after mixing for 3 minutes, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding lycopene into 4kg of deionized water and uniformly mixing for later use, and simultaneously adding curcumin into 4kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, a lycopene aqueous solution is added into a mixer and mixed with solid materials in the mixer, the mixture is stirred and mixed for 15 minutes through the mixer, the mixture is filtered through a 20-mesh screen, the filtered mixed materials are added into the mixer again, a curcumin aqueous solution is added into the mixer and mixed and stirred for 10 minutes, the mixture is transferred into a granulator and granulated through a 20-mesh screen, the prepared semi-finished granules are dried for 2 hours at 60 ℃ in a hot air circulation oven, and the granules are granulated through the 20-mesh screen to obtain finished product hangover alleviating granules;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 5 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
Meanwhile, after the processing treatment in the step S1, the residual hawthorn and kudzu vine root residues and the filtered filter residues are gathered, saccharomycetes accounting for 10% of the total amount of the residues and the filter residues are added into the residues and the filter residues and are uniformly mixed, then the mixture is pressed into a filter cake with a block structure, the thickness of the filter cake is 10 cm, the length and the width of the filter cake are not more than 30 cm, the water content of the filter cake is not more than 4%, and in the step S1, the total amount of deionized water is 5 times of the total amount of the hawthorn and.
In addition, in the step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 30% of the thickness of the auxiliary layer.
The auxiliary layer is mainly composed of the following substances in percentage by mass: 15% of schisandra chinensis powder, 7% of salvia miltiorrhiza powder, 7% of licorice powder, 5.3% of gardenia powder, 21% of yam powder, 11.7% of semen cassiae powder and the balance of refined honey, wherein the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the semen cassiae powder are all 100 meshes, and the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the semen cassiae powder are all freeze-dried powders.
In addition, the functional layer is composed of the following substances in percentage by mass: 15% of L-arabinose, 11% of maltitol, 7.1% of carboxymethyl cellulose, 5.3% of sulfur-containing amino acid, 4.1% of inositol, 14.5% of glucose, 2.5% of acetic acid bacteria freeze-dried powder and the balance of milk powder.
As shown in fig. 2, a method for constructing an anti-hangover and liver-protecting tablet, comprises the following steps:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria lyophilized bacteria powder and milk powder at the constant temperature of 40 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and performing air drying operation by using cold air at 5 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
Example 3
As shown in fig. 1, an anti-hangover and liver-protecting tablet comprises the following components in percentage by mass: 15% of hawthorn, 5% of kudzuvine root, 11% of corn oligopeptide powder, 8.3% of oyster peptide, 3.8% of xylo-oligosaccharide, 1.8% of vitamin C, 2.5% of L-leucine, 0.9% of L-glutamic acid, 0.1% of L-cysteine, 0.5% of glycine, 2.5% of citric acid, 2.4% of L-malic acid, 0.8% of taurine, 0.11% of aspartame (containing phenylalanine), 0.31% of acesulfame potassium, 1.8% of magnesium stearate, 0.2% of lycopene, 0.8% of curcumin and the balance of lactose.
A preparation method of an anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 100 ℃, wherein the decocting time is 1.2 hours each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to the normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the secondary decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 70 ℃ to obtain thick paste with the relative density of 1.36 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain extract powder of 100 meshes;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 30 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 15 minutes after mixing for 2 minutes, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding lycopene into 2kg of deionized water and uniformly mixing for later use, and simultaneously adding curcumin into 2.5kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, the lycopene aqueous solution is added into a mixer and mixed with solid materials in the mixer, then the mixture is stirred and mixed for 10 minutes through the mixer, then the mixture is filtered through a 15-mesh screen, the filtered mixed materials are added into the mixer again, then the curcumin aqueous solution is added into the mixer and mixed and stirred for 8 minutes, finally the mixture is transferred into a granulator and granulated through a 15-mesh screen, then the prepared semi-finished granules are dried for 1.2 hours at 55 ℃ in a hot air circulation oven, and finally the granules are granulated through the 15-mesh screen to obtain finished product particles for dispelling the effects of the alcohol;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 3 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
Preferably, the hawthorn and kudzu vine root residues left after the processing treatment in the step S1 and the filtered filter residues are collected, saccharomycetes accounting for 8% of the total amount of the residues and the filter residues are added into the residues and the filter residues and are uniformly mixed, and then the mixture is pressed into a filter cake with a block structure, wherein the thickness of the filter cake is 5 cm, the length and the width of the filter cake are not more than 30 cm, and the water content of the filter cake is not more than 4%.
In addition, the total amount of the deionized water in the step of S1 is 3 times of the total amount of the hawthorn and the kudzuvine root.
It is emphasized that, in the step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 15% of the thickness of the auxiliary layer.
Meanwhile, the auxiliary layer consists of the following substances in percentage by mass: 12% of schisandra chinensis powder, 5% of salvia miltiorrhiza powder, 4.7% of licorice powder, 3.3% of gardenia powder, 15% of yam powder, 7.7% of semen cassiae powder and the balance of refined honey, wherein the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the semen cassiae powder are all 80 meshes, and the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the semen cassiae powder are all freeze-dried powders.
Meanwhile, the functional layer consists of the following substances in percentage by mass: 13% of L-arabinose, 8% of maltitol, 6.1% of carboxymethyl cellulose, 4.3% of sulfur-containing amino acid, 3.1% of inositol, 12.5% of glucose, 1.5% of acetic acid bacteria freeze-dried powder and the balance of milk powder.
As shown in fig. 2, a method for constructing an anti-hangover and liver-protecting tablet, comprises the following steps:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria lyophilized bacteria powder and milk powder at the constant temperature of 25 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and performing air drying operation by using cold air at 0 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
Example 4
As shown in fig. 1, an anti-hangover and liver-protecting tablet comprises the following components in percentage by mass: 20% of hawthorn, 6.1% of kudzuvine root, 14.3% of corn oligopeptide powder, 9.3% of oyster peptide, 3.8% of xylo-oligosaccharide, 2.2% of vitamin C, 2.3% of L-leucine, 0.9% of L-glutamic acid, 0.11% of L-cysteine, 0.9% of glycine, 1.5% of citric acid, 2.1% of L-malic acid, 1.1% of taurine, 0.13% of aspartame (containing phenylalanine), 0.34% of acesulfame potassium, 2% of magnesium stearate, 0.25% of lycopene, 0.4% of curcumin and the balance of lactose.
A preparation method of an anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 95 ℃, wherein the decocting time is 1.8 hours each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to the normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the secondary decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 75 ℃ to obtain thick paste with the relative density of 1.37 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain extract powder of 200 meshes;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 35 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 20 minutes after mixing for 2 minutes, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding the lycopene into 2.1kg of deionized water and uniformly mixing for later use, and simultaneously adding the curcumin into 3.5kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, the lycopene aqueous solution is added into a mixer and mixed with solid materials in the mixer, then the mixture is stirred and mixed for 11 minutes through the mixer, then the mixture is filtered through a 15-mesh screen, the filtered mixed materials are added into the mixer again, then the curcumin aqueous solution is added into the mixer and mixed and stirred for 8 minutes, finally the mixture is transferred into a granulator and granulated through a 20-mesh screen, then the prepared semi-finished granules are dried for 1.7 hours at 55 ℃ in a hot air circulation oven, and finally the granules are granulated through the 15-mesh screen to obtain finished product particles for dispelling the effects of the alcohol;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 4 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
Meanwhile, after the processing treatment in the step S1, the residual hawthorn and kudzu vine root residues and the filtered filter residues are gathered, saccharomycetes accounting for 6% of the total amount of the residues and the filter residues are added into the residues and the filter residues and are uniformly mixed, then the mixture is pressed into a filter cake with a block structure, the thickness of the filter cake is 9 cm, the length and the width of the filter cake are not more than 30 cm, the water content of the filter cake is not more than 4%, and in the step S1, the total amount of deionized water is 3.4 times of the total amount of the hawthorn and.
Meanwhile, in the step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 28% of the thickness of the auxiliary layer.
The auxiliary layer is mainly composed of the following substances in percentage by mass: 11% of schisandra chinensis powder, 4.1% of salvia miltiorrhiza powder, 4.6% of licorice powder, 3.3% of gardenia powder, 14.5% of yam powder, 9.7% of cassia seed powder and the balance of refined honey, wherein the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the cassia seed powder are all 80 meshes, and the schisandra chinensis powder, the salvia miltiorrhiza powder, the licorice powder, the gardenia powder, the yam powder and the cassia seed powder are all freeze-dried powders.
Meanwhile, the functional layer consists of the following substances in percentage by mass: 11.5 percent of L-arabinose, 7 percent of maltitol, 6.1 percent of carboxymethyl cellulose, 4.3 percent of sulfur-containing amino acid, 3.5 percent of inositol, 10.5 percent of glucose, 1.3 percent of acetic acid bacteria freeze-dried powder and the balance of milk powder.
As shown in fig. 2, a method for constructing an anti-hangover and liver-protecting tablet, comprises the following steps:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria lyophilized bacteria powder and milk powder at the constant temperature of 28 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and performing air drying operation by using cold air at 3 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
In practical use, after the invention is taken, the invention enters the digestive tract of a human body and is characterized in that:
firstly, a functional layer of a coating layer is dissolved firstly, and after the functional layer is dissolved, on one hand, L-arabinose of the functional layer can effectively inhibit the absorption capacity of a human digestive system and reduce the absorption capacity of the human body to alcohol, on the other hand, carboxymethyl cellulose contains sulfur amino acid, inositol and glucose and can effectively nourish the digestive system and reduce the loss of alcohol and medicaments to the digestive system;
then, the medicine and nutrient components of the coated layer schisandra chinensis powder, the salvia miltiorrhiza powder, the liquorice powder, the gardenia powder, the yam powder and the cassia seed powder enter the blood from the copper drum digestive system, so that the purposes of nourishing the digestive system, the liver and the kidney, improving the metabolism level of human organ systems, accelerating the decomposition and excretion efficiency of alcohol, reducing the harm of alcohol to the human body, improving the cell activity of the digestive system, the liver and the kidney of the human body, reducing the damage of alcohol to human cells, effectively improving the absorption, transportation and transformation capacity of the human body to nutrient substances and keeping the digestive system, the liver and the kidney of the human body at a higher physiological activity level are achieved;
finally, after the coating layer preliminarily inhibits the alcohol absorption capacity of the human digestive system and preliminarily protects and improves the physiological level of the human digestive system, liver, kidney and other organs, the absorption, transportation and transformation capacities of nutritional ingredients and medicinal ingredients of components such as hawthorn, kudzuvine root, corn oligopeptide powder, oyster peptide, xylo-oligosaccharide, vitamin, L-leucine, L-glutamic acid, L-cysteine, glycine, citric acid, L-malic acid, taurine, aspartame (containing phenylalanine), acesulfame potassium, magnesium stearate, lycopene, curcumin, lactose and the like which form the anti-alcoholism granule are effectively improved through a digestive system with high physiological activity level, the defect that the efficacy of the medicinal ingredients is not fully exerted due to the insufficient function of the digestive system of a human body in the traditional anti-alcoholism product is overcome, thereby further improving the efficiency of relieving alcoholism and the nourishing capability to human liver and other organs while relieving alcoholism.
The invention has wide raw material sources, low cost and small toxic and side effects, and on one hand, the invention can effectively reduce the absorption efficiency and absorption amount of human body to alcohol, effectively improve the metabolism level of human body, accelerate the decomposition capability of human body to alcohol and the excretion capability of alcohol from human body, thereby achieving the purposes of quickly dispelling the effects of alcohol and sobering up and reducing the adverse effects of alcohol on the digestive system and nervous system of human body; on the other hand, the alcohol-containing liver-protecting health-care wine can effectively reduce the damage of alcohol to the liver, prevent fat from accumulating at the liver part, effectively improve the regeneration capacity of stem cells, recover and improve the comprehensive physiological function of the liver, promote bile secretion, further improve the digestive capacity of a human body, eliminate the burden and adverse effect of alcohol on the digestive system of the human body, and quickly recover the physiological function of the human body, thereby effectively realizing the liver nourishing and protecting capacity while improving the capacity of dispelling the effects of alcohol.
The foregoing shows and describes the general principles and broad features of the present invention and advantages thereof. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the specification and illustrated only to illustrate the principle of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the present invention, which fall within the scope of the invention as claimed. The scope of the invention is defined by the appended claims and equivalents thereof.
Claims (9)
1. An anti-alcohol liver-protecting tablet is characterized in that: the alcohol-relieving and liver-protecting tablet is composed of the following substances in percentage by mass: 10-22% of hawthorn, 3-7% of radix puerariae, 8.5-17% of corn oligopeptide powder, 6.3-12.3% of oyster peptide, 2.5-5.8% of xylo-oligosaccharide, 1.3-2.7% of vitamin C, 1.1-3.5% of L-leucine, 0.3-1.4% of L-glutamic acid, 0.05-0.15% of L-cysteine, 0.11-1.4% of glycine, 0.8-3.5% of citric acid, 1.5-3.5% of L-malic acid, 0.3-1.8% of taurine, 0.01-0.21% of aspartame (containing phenylalanine), 0.3-0.35% of acesulfame potassium, 1.3-2.7% of magnesium stearate, 0.1-0.4% of lycopene, 0.3-1.1% of curcumin and the balance of lactose.
2. A preparation method of a tablet for relieving alcoholism and protecting liver is characterized by comprising the following steps: the preparation method of the anti-alcohol liver-protecting tablet comprises the following steps:
s1, preparing extract powder, adding deionized water into the hawthorn and the kudzuvine root, decocting twice at a constant temperature of 90-110 ℃, wherein the decocting time is 1-2 hours each time, filtering and collecting decoction after the first decoction is finished, naturally cooling the decoction, the residual hawthorn and the kudzuvine root to normal temperature, then adding deionized water into the residual hawthorn and the kudzuvine root for secondary decoction, filtering the secondary decoction after the decoction is finished, and mixing the filtered decoction with the first decoction; then filtering the mixed decoction, collecting the filtrate in a centralized manner, heating and concentrating the filtrate at the constant temperature of 60-80 ℃ to obtain thick paste with the relative density of 1.35-1.38 after the filtrate is collected, finally drying the thick paste in vacuum, and crushing the dried solid material to obtain extract powder of 80-500 meshes;
s2, mixing the materials, adding the extract powder obtained in the step S1, lactose, citric acid, L-malic acid and oyster peptide into a mixing device, mixing at the constant temperature of 20-40 ℃, adding vitamin C, aspartame, acesulfame potassium and taurine into a mixing machine for continuously mixing for 10-30 minutes after mixing for 1-3 minutes, and then intensively storing the mixed solid materials in the mixing machine for later use;
s3, preparing a solution, after the step S2 is completed, adding the lycopene into 1-4 kg of deionized water and uniformly mixing for later use, and simultaneously adding the curcumin into 1-4 kg of deionized water and uniformly mixing for later use;
s4, granulating, wherein after the step S3 is completed, a lycopene water solution is added into a mixer and mixed with solid materials in the mixer, the mixture is stirred and mixed for 5-15 minutes through the mixer, the mixture is filtered through a 12-20-mesh screen, the filtered mixed materials are added into the mixer again, a curcumin water solution is added into the mixer and mixed and stirred for 2-10 minutes, finally the mixture is transferred into a granulator and granulated through a 12-20-mesh screen, the prepared semi-finished granules are dried for 1-2 hours at 50-60 ℃ in a hot air circulation oven, and finally, the granules are granulated through a 14-20-mesh screen to obtain finished product particles for dispelling effects of alcohol;
and S5, coating, namely conveying the finished product of the hangover alleviating granules obtained in the step S4 into coating equipment, and coating a coating layer with the thickness of 1-5 mm on the outer surface of the hangover alleviating granules to obtain the finished product of the hangover alleviating and liver protecting tablet.
3. The construction method of the alcohol-relieving liver-protecting tablet according to claim 2, wherein the construction method comprises the following steps: and (3) concentrating the residual hawthorn and kudzu root residues and the filtered filter residues after the processing treatment in the step S1, adding saccharomycetes accounting for 1-10% of the total amount of the residues and the filter residues into the residues and the filter residues, uniformly mixing, pressing into a filter cake with a block structure, wherein the thickness of the filter cake is 3-10 cm, the length and the width of the filter cake are not more than 30 cm, and the water content of the filter cake is not more than 4%.
4. The construction method of the alcohol-relieving liver-protecting tablet according to claim 2, wherein the construction method comprises the following steps: the total amount of the deionized water in the step S1 is 2.5-5 times of the total amount of the hawthorn and the kudzuvine root.
5. The construction method of the alcohol-relieving liver-protecting tablet according to claim 2, wherein the construction method comprises the following steps: in step S5, the coating layer includes an auxiliary layer and a functional layer from the inside to the outside, wherein the thickness of the functional layer is 10% to 30% of the thickness of the auxiliary layer.
6. The construction method of the alcohol-relieving liver-protecting tablet according to claim 5, wherein the construction method comprises the following steps: the auxiliary layer is composed of the following substances in percentage by mass: 10-15% of schisandra chinensis powder, 3-7% of salvia miltiorrhiza powder, 3.5-7% of liquorice powder, 2.3-5.3% of gardenia powder, 11-21% of yam powder, 5.3-11.7% of cassia seed powder and the balance of refined honey.
7. The construction method of the alcohol-relieving liver-protecting tablet according to claim 5, wherein the construction method comprises the following steps: the schisandra chinensis powder, the salvia miltiorrhiza powder, the liquorice powder, the gardenia powder, the yam powder and the cassia seed powder are all 20-100 meshes, and the schisandra chinensis powder, the salvia miltiorrhiza powder, the liquorice powder, the gardenia powder, the yam powder and the cassia seed powder are all freeze-dried powders.
8. The construction method of the alcohol-relieving liver-protecting tablet according to claim 5, wherein the construction method comprises the following steps: the functional layer is composed of the following substances in percentage by mass: 10-15% of L-arabinose, 5-11% of maltitol, 3.5-7.1% of carboxymethyl cellulose, 2.3-5.3% of sulfur-containing amino acid, 2.5-4.1% of inositol, 8.6-14.5% of glucose, 1-2.5% of acetic acid bacteria freeze-dried powder and the balance of milk powder.
9. The construction method of the alcohol-relieving liver-protecting tablet according to claim 2, wherein the construction method comprises the following steps: when the coating operation is performed in the step S5:
firstly, mixing materials for preparation, namely heating refined honey to a molten state, adding schisandra chinensis powder, salvia miltiorrhiza powder, liquorice powder, gardenia powder, yam powder and semen cassiae powder into the refined honey, and uniformly stirring to obtain a liquid auxiliary layer for later use; simultaneously stirring and mixing L-arabinose, maltitol, carboxymethyl cellulose, sulfur-containing amino acid, inositol, glucose, acetic acid bacteria freeze-dried bacteria powder and milk powder at the constant temperature of 20-40 ℃ to obtain a powdery functional layer for later use;
secondly, primary coating, namely directly coating the liquid auxiliary layer prepared in the first step on the outer layer of the finished product hangover alleviating granule prepared in the step S4, granulating again, and carrying out air drying operation by cold wind at-5 ℃ to obtain a semi-finished product hangover alleviating and liver protecting tablet;
and thirdly, press-molding, namely mixing the semi-finished product of the alcohol-relieving and liver-protecting tablet prepared in the second step with the powdery functional layer prepared in the first step, so that the powdery functional layer is coated outside the semi-finished product of the alcohol-relieving and liver-protecting tablet, and press-molding the mixture by a tablet press to obtain the finished product of the alcohol-relieving and liver-protecting tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010372855.2A CN111990641A (en) | 2020-05-06 | 2020-05-06 | Alcohol-dispelling liver-protecting tablet and construction method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010372855.2A CN111990641A (en) | 2020-05-06 | 2020-05-06 | Alcohol-dispelling liver-protecting tablet and construction method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111990641A true CN111990641A (en) | 2020-11-27 |
Family
ID=73461456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010372855.2A Pending CN111990641A (en) | 2020-05-06 | 2020-05-06 | Alcohol-dispelling liver-protecting tablet and construction method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111990641A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113197268A (en) * | 2021-06-07 | 2021-08-03 | 安徽双中科技产业有限公司 | Sobering and liver-protecting soft drink and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747723A (en) * | 2003-02-05 | 2006-03-15 | 爱的发 | Composition comprising a mixture of active principles, and method of preparation |
CN101731630A (en) * | 2010-01-22 | 2010-06-16 | 完美(中国)日用品有限公司 | Health-care food with effects of neutralizing effect of alcoholic drinks and protecting liver |
CN105010937A (en) * | 2015-08-11 | 2015-11-04 | 山东福田药业有限公司 | L-arabinose anti-alcohol pill and preparation method thereof |
CN106309600A (en) * | 2015-06-24 | 2017-01-11 | 张学成 | Prescription and preparation process of de-alcoholic oral composition |
CN106858244A (en) * | 2017-02-17 | 2017-06-20 | 陕西必康制药集团控股有限公司 | Maize oligopeptide sobering-up beverage and preparation method thereof |
-
2020
- 2020-05-06 CN CN202010372855.2A patent/CN111990641A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1747723A (en) * | 2003-02-05 | 2006-03-15 | 爱的发 | Composition comprising a mixture of active principles, and method of preparation |
CN101731630A (en) * | 2010-01-22 | 2010-06-16 | 完美(中国)日用品有限公司 | Health-care food with effects of neutralizing effect of alcoholic drinks and protecting liver |
CN106309600A (en) * | 2015-06-24 | 2017-01-11 | 张学成 | Prescription and preparation process of de-alcoholic oral composition |
CN105010937A (en) * | 2015-08-11 | 2015-11-04 | 山东福田药业有限公司 | L-arabinose anti-alcohol pill and preparation method thereof |
CN106858244A (en) * | 2017-02-17 | 2017-06-20 | 陕西必康制药集团控股有限公司 | Maize oligopeptide sobering-up beverage and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
张伦编著: "《《智者的医生就是自己 张伦谈保健》》", 30 November 2017, 河北科学技术出版社 * |
张小斌等: "调脂护肝茶治疗高脂血症合并脂肪肝的临床研究", 《江苏中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113197268A (en) * | 2021-06-07 | 2021-08-03 | 安徽双中科技产业有限公司 | Sobering and liver-protecting soft drink and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1284467C (en) | Instant balsam pear cold tea and its making method | |
CN106667915B (en) | It is a kind of for treating the scutelloside aluminium dry suspensoid agent of grice diarrhoea | |
CN111264740A (en) | Solid beverage and preparation method thereof | |
CN102349651B (en) | Health care food with functions of enhancing immunity and easing fatigue and preparation method thereof | |
CN106362020B (en) | A kind of pine pollen composition and preparation method thereof with improvement defecating feces excretion | |
CN102266452A (en) | Chinese medicinal composition for enhancing anoxia endurance and preparation method and application thereof | |
CN111990641A (en) | Alcohol-dispelling liver-protecting tablet and construction method thereof | |
CN106261450A (en) | A kind of Haematococcus Pluvialis effervescent tablet of heat clearing away and internal heat reducing and preparation method thereof | |
CN107439787B (en) | Walnut oligopeptide with PM 2.5 particle resistance effect | |
CN111870627A (en) | Sobering-up preparation and its preparing method and use | |
CN1278721C (en) | Composite preparation of defatting and shaping body by consuming fat and its preparing method | |
CN104013733A (en) | Chitosan composition for prevention and treatment of chemical liver injury and preparation method thereof | |
CN114984098B (en) | Hawthorn chicken gizzard-skin chewable tablet and preparation method thereof | |
CN109010514A (en) | Composition, health care product and the preparation method of altitude sickness prevention | |
CN105597081A (en) | Medicine for reducing hypertension | |
CN113662992B (en) | Application of pyracantha fortuneana fruit and medicine for treating platelet-related diseases | |
CN110024985A (en) | Selenium-enriched wolfberry fruit chewable tablets and preparation method thereof | |
CN115252501A (en) | Acne-curing composition and preparation method and application thereof | |
CN115251271A (en) | Medicinal and edible spleen tonifying electuary and preparation method thereof | |
CN108578578B (en) | Pharmaceutical composition with blood fat reducing effect and preparation method thereof | |
CN113499366A (en) | Composition with function of reducing blood sugar and blood fat simultaneously and preparation method thereof | |
CN110585321A (en) | Traditional Chinese medicine composition for preventing and treating anemia and preparation method and application thereof | |
CN115006355B (en) | Preparation method of veterinary coptis chinensis granules with full-component extraction | |
CN1060663C (en) | Compound Tibet capillary artemisia patent medicine | |
CN110917312B (en) | Chinese patent medicine for treating children's spleen-lung qi deficiency type cough variant asthma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201127 |
|
RJ01 | Rejection of invention patent application after publication |